Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T16291 | NF157 | COX | Immunology/Inflammation; Neuroscience |
NF157 significantly decreases the expression of metalloproteinase (MMP)-3, MMP-13, which can be used in the treatment of osteoarthritis (OA). NF157 is a highly selective nanomolar P2Y11 antagonist (pKi: 7.35). The IC50s are 463 nM, 1811 µM, 170 µM for P2Y |